Parkinson's disease — response to opicapone
1 article(s) in the watch · Pharmacogenomics
Effect of COMT and UGT1A Variants on Clinical Response to Opicapone in Parkinson's Disease.
Automatic aggregation page — a clinical introduction may be added.